Fougerousse F - Search Results

1

Arginine butyrate: a therapeutic candidate for Duchenne muscular dystrophy.

Vianello S, Yu H, Voisin V, Haddad H, He X, Foutz AS, Sebrié C, Gillet B, Roulot M, Fougerousse F, Perronnet C, Vaillend C, Matecki S, Escolar D, Bossi L, Israël M, de la Porte S. Vianello S, et al. Among authors: fougerousse f. FASEB J. 2013 Jun;27(6):2256-69. doi: 10.1096/fj.12-215723. Epub 2013 Feb 21. FASEB J. 2013. PMID: 23430975 Free article.

2

Force impairment in calpain 3-deficient mice is not correlated with mechanical disruption.

Fougerousse F, Gonin P, Durand M, Richard I, Raymackers JM. Fougerousse F, et al. Muscle Nerve. 2003 May;27(5):616-23. doi: 10.1002/mus.10368. Muscle Nerve. 2003. PMID: 12707983

3

Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping.

Goyenvalle A, Vulin A, Fougerousse F, Leturcq F, Kaplan JC, Garcia L, Danos O. Goyenvalle A, et al. Among authors: fougerousse f. Science. 2004 Dec 3;306(5702):1796-9. doi: 10.1126/science.1104297. Epub 2004 Nov 4. Science. 2004. PMID: 15528407

4

[An opening in Duchenne muscular dystrophy: persistent therapeutic rescue of dystrophin by vectorized antisense mediated exon skipping in mdx mice].

Goyenvalle A, Vulin A, Fougerousse F, Leturcq F, Kaplan JC, Garcia L, Danos O. Goyenvalle A, et al. Among authors: fougerousse f. Med Sci (Paris). 2004 Dec;20(12):1163-5. doi: 10.1051/medsci/200420121163. Med Sci (Paris). 2004. PMID: 15581476 Free article. French. No abstract available.

5

Pre-clinical study of 21 approved drugs in the mdx mouse.

Carre-Pierrat M, Lafoux A, Tanniou G, Chambonnier L, Divet A, Fougerousse F, Huchet-Cadiou C, Ségalat L. Carre-Pierrat M, et al. Among authors: fougerousse f. Neuromuscul Disord. 2011 May;21(5):313-27. doi: 10.1016/j.nmd.2011.01.005. Epub 2011 Mar 9. Neuromuscul Disord. 2011. PMID: 21392993

6

Cardiac characterization of mdx mice using high-resolution doppler echocardiography.

Fayssoil A, Renault G, Guerchet N, Marchiol-Fournigault C, Fougerousse F, Richard I. Fayssoil A, et al. Among authors: fougerousse f. J Ultrasound Med. 2013 May;32(5):757-61. doi: 10.7863/ultra.32.5.757. J Ultrasound Med. 2013. PMID: 23620316

7

Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A.

Bartoli M, Roudaut C, Martin S, Fougerousse F, Suel L, Poupiot J, Gicquel E, Noulet F, Danos O, Richard I. Bartoli M, et al. Among authors: fougerousse f. Mol Ther. 2006 Feb;13(2):250-9. doi: 10.1016/j.ymthe.2005.09.017. Epub 2005 Nov 14. Mol Ther. 2006. PMID: 16290124 Free article.

8

Phenotypic correction of alpha-sarcoglycan deficiency by intra-arterial injection of a muscle-specific serotype 1 rAAV vector.

Fougerousse F, Bartoli M, Poupiot J, Arandel L, Durand M, Guerchet N, Gicquel E, Danos O, Richard I. Fougerousse F, et al. Mol Ther. 2007 Jan;15(1):53-61. doi: 10.1038/sj.mt.6300022. Mol Ther. 2007. PMID: 17164775 Free article.

9

Human-mouse differences in the embryonic expression patterns of developmental control genes and disease genes.

Fougerousse F, Bullen P, Herasse M, Lindsay S, Richard I, Wilson D, Suel L, Durand M, Robson S, Abitbol M, Beckmann JS, Strachan T. Fougerousse F, et al. Hum Mol Genet. 2000 Jan 22;9(2):165-73. doi: 10.1093/hmg/9.2.165. Hum Mol Genet. 2000. PMID: 10607827

10

Calpain3 expression during human cardiogenesis.

Fougerousse F, Anderson LV, Delezoide AL, Suel L, Durand M, Beckmann JS. Fougerousse F, et al. Neuromuscul Disord. 2000 Jun;10(4-5):251-6. doi: 10.1016/s0960-8966(99)00107-8. Neuromuscul Disord. 2000. PMID: 10838251

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page